Migraine drug joins fight against deadly pancreatic cancer
NCT ID NCT07475234
Summary
This study is testing if adding a drug called rimegepant, which is normally used for migraines, to standard chemotherapy can help people with advanced pancreatic cancer that has spread. The goal is to see if this combination can better control the cancer and delay its progression. The study will involve about 30 adults who have not had prior treatment for their metastatic pancreatic cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.